Ferroptosis is a regulated form of necrotic cell death caused by the accumulation of lipid peroxides. It can be induced by inhibiting glutathione peroxidase 4 (GPX4), the key enzyme for lipid peroxides reduction from phospholipid membranes. Recent studies have identified metabolic and genetic contributors to ferroptosis. However, many mechanisms of resistance or sensitivity to ferroptosis remain unknown. Here, we show that low cell density sensitizes primary mammary epithelial and breast cancer cells to induction of ferroptosis by GPX4 inhibition, whereas high cell density confers resistance.
Introduction
A novel, regulated cell-death modality termed ferroptosis was recently described in specific cancer entities and other pathological settings [1, 2] . Ferroptosis is caused by the accumulation of peroxidized lipids (lipoxygenation) and can be triggered by inhibition or genetic inactivation of glutathione peroxidase 4 (GPX4), the key enzyme in the removal of lipid hydroperoxides (L-OOH) from membrane phospholipids [2, 3] . As its name indicates, ferroptosis is also dependent on intracellular iron, which is required for the accumulation of lipid hydroperoxides [1] . Moreover, cysteine availability affects glutathione (GSH) metabolism [4] , and thus GPX4 activity and ferroptosis [1, 2, 5] . Apart from amino acid metabolism, lipid metabolism emerges as a determinant of ferroptosis sensitivity. In this context, the enzyme Acyl-CoA synthethase long chain family member 4 (ACSL4) has been shown to sensitize cells to ferroptosis by activating long-chain polyunsaturated fatty acids (PUFAs) through formation of PUFA acyl-CoA (PUFA-CoA).
PUFA-CoA are esterified into phosphatidylethanolamines (PE) which serve as a death signal for execution of ferroptosis [6, 7] . However, despite these insights into molecular mechanisms, a better understanding of cellular and metabolic states that confer sensitivity or resistance to ferroptosis is crucial in order to exploit it for therapeutic purposes. These encompass triggering ferroptosis in cancer cells, as well as protecting cells from ferroptosis in other pathological conditions such as ischemia/reperfusion injury resulting in a full EMT (Fig EV1 A and B) . As a control, an inactive diastereoisomer of RSL3 did not induce cell death at any cell density (Fig EV1A) . Immunoblotting for GPX4 revealed that HMLE-Twist1 cells expressed 2.3-2.6 fold higher levels of GPX4 protein than HMLE cells. However, cell density itself did not have an effect on GPX4 protein expression ( Fig 1D) . Together, these data suggested that cell density is a critical factor sensitizing cells to GPX4 inhibition independent of whether HMLE cells were in an epithelial or mesenchymal state, thus contrasting with the recent finding that EMT predisposes cells to ferroptosis [14] .
To confirm that ferroptosis was indeed the observed modality of cell death, we treated cells at low seeding density with zVAD-fmk (zVAD), thereby blocking caspase activity [15] , and Nec1-S, an inhibitor of the receptor-interacting protein kinase 1 (RIPK1) [16] .
We also used Ferrostatin1 (Fer1) and Liproxstatin1 (Lip1) as known inhibitors of ferroptosis [1, 9] . Indeed, we observed that RSL3-induced cell death was only rescued by treatment with Fer1 or Lip1, but not zVAD or Nec1-S, suggesting that neither apoptosis nor necrosis, respectively, are involved (Fig 1E, EV1C ). In addition, immunoblotting showed no cleavage of caspase 3 or its downstream target PARP upon RSL3-treatment in both HMLE and HMLE-Twist1 cells, further ruling out apoptosis as a cell-death modality (Fig 1F) [17, 18] .
To confirm that ferroptosis-induction at low cell density was exclusively dependent on GPX4-inhibition and not related to off-target effects or simply overall change in the ratio of inhibitor molecules and cell number, we knocked out GPX4. Using CRISPR/Cas9, we derived several single cell clones (SCCs) with and without detectable GPX4 protein expression (GPX4-WT and GPX4-KO, respectively, Fig 1G) . Since gene knockout of growth medium. In addition, treatment with Fer1 maintained viability as well (Fig EV1D) .
Upon withdrawal of Lip1, we again observed induction of cell death only at a low cell density in three GPX4-KO SCCs of both HMLE and HMLE-Twist1 cells (Fig 1H) similar to what was reported for Tamoxifen-inducible GPX4 knockout fibroblasts [3] .
Importantly, SCCs with intact GPX4 expression still showed density-dependent cell death upon RSL3 treatment, suggesting that selected SCCs are representative of the respective bulk population (Fig EV1E and F) . In conclusion, we observed that celldensity determines sensitivity to ferroptosis in both epithelial and Twist1-expressing mesenchymal HMLE cells.
Cell-density dependent cell death is not affected by oncogenic signaling and occurs in primary mammary epithelial cells
Next, we addressed whether oncogenic signaling affects density-dependent sensitivity to ferroptosis. However, both HMLE cells overexpressing HRas or neuNT oncogenes and HMLE-Twist1 cells overexpressing HRas remained resistant to RSL3-induced cell death at high seeding densities and died at low cell densities, similar to their parental cells (Fig 2A and EV2A) . In addition, we tested whether deletion of the tumor suppressor PTEN altered sensitivity to RSL3-treatment, but again, we did not see an effect beyond cell density ( Figure 2B and EV2B). In conclusion, neither oncogenic signaling nor an epithelial or a mesenchymal cell state impacted cell-density dependent cell death.
Interestingly, investigation of an association between the mutation status of RAS and ferroptosis sensitivity in 117 cancer cell lines did not reveal a selective lethality [21] , further supporting the notion that still poorly understood and reversible, non-mutational mechanisms regulate ferroptosis-sensitivity.
.
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To determine whether cell-density dependent ferroptosis-sensitivity constitutes an intrinsic property of mammary epithelial cells, primary human mammary epithelial cells (HMECs) isolated from three different donors (M1, M2 and M3) were treated with RSL3 ( Fig 2C) . In addition, we included prospectively isolated primary cells of the basal lineage to dissect whether lineage identity had an effect on sensitivity to ferroptosis induction ( Fig EV2C) [22] [12] . Again, we observed density-dependent cell death by RSL3 to a similar extent in all samples. Importantly, this effect occurred both in ambient oxygen atmosphere (20%) as well as 3% oxygen, the latter mimicking physiological tissue pressure (Fig 2C and EV2C) . Together, these data indicate that cell-density dependent sensitivity to ferroptosis is a trait present in primary HMECs and does not arise as an artefact of long-term culture and selection.
GPX4-inhibition prevents organoid-generation in 3D-collagen gels
Next, we wished to determine whether density-dependent sensitivity to ferroptosis could be observed when cells are grown in a 3D-environment, thus mimicking a physiological environment. For this purpose, we plated primary HMEC into an organoid assay as previously described [22] . Specifically, bulk primary HMEC as well as prospectively isolated cells of the basal (B, CD10 + /CD49f hi /EpCAM − ) and luminal progenitor lineage (L, CD10 − /CD49f + /EpCAM + ) were plated into 3D-collagen gels. After initial establishment of cultures from single cells and before the onset of organoid formation, RSL3, Lip1 or a combination of both were added to the growth medium every 2-3 days. In the DMSO control and Lip1-treated cells, basal cells gave rise to branched organoids and luminal cells formed spheres, while bulk cells gave rise to different kind of colonies including branched organoids and spheres (Fig 2D and EV2D) , as reported previously [22] . RSL3-. CC-BY-NC-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint treatment strongly inhibited colony formation, an effect that was partially rescued by concomitant treatment with Lip1 (60-100% of control, Fig 2D and EV2D ). In addition, in contrast to control and rescued samples, we observed a complete absence of proliferation marker Ki67 in the few remaining small clusters of cells in RSL3-treated cultures (Fig 2E) . Together, these data suggested that primary HMEC are highly sensitive to GPX4-inhibition during organoid formation from single cells.
To provide further support for these observations, HMLE GPX4-KO SCCs were seeded at different densities in 3D-collagen gels in medium with (+Lip1) or without Lip1 (−Lip1) or cultured for three days in Lip1-containing medium with subsequent Lip1-withdrawal (+/−Lip1, Fig 2F) . This allowed us to test whether cells remain sensitive to ferroptosis once small colonies have formed. As previously described in HMLE cells, GPX4-KO SCCs generated multicellular spheres in Lip1-containing medium (Fig EV2E) [12].
Similar to low seeding densities in 2D-cultures, immediate withdrawal of Lip1 in 3D-cultures resulted in complete growth-inhibition (Fig 2F and EV2E) . In contrast, Lip1-withdrawal after three days of 3D-culture enabled colony-formation in similar numbers compared to culture in Lip1-containing growth medium. These data indicated that once colonies have formed, they acquire resistance to cell death induction by GPX4 knockout.
However, both colony-size as well as proliferation assessed by Ki67 staining were reduced in this condition, suggesting that Lip1-withdrawal at later timepoints restricts further expansion in 3D-cultures (Fig 2F and G) . Together, these data indicate that, similar to low seeding densities in 2D-culture, both primary HMEC as well as HMLE cells are sensitive to ferroptosis at low cell-density in 3D-culture. However, the observation that HMLE GPX4-KO SCCs were partially protected from ferroptosis upon Lip1-withdrawal once small colonies had formed, suggests an intrinsic mechanism that . CC-BY-NC-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint protects epithelial tissues from ferroptosis. In line with these data, a recent study showed that in immortalized non-tumorigenic MCF10A cells and a panel of breast cancer cell lines, detachment of cells from the extracellular matrix (ECM) triggers ferroptosis [23] . Further, it was shown that Tamoxifen-inducible GPX4-knockout fibroblasts are capable of tumor formation when implanted subcutaneously in mice at very high numbers (5 million) [24] .
Cell density-dependent death induced by GPX4-inhibition is dependent on iron and lipoxygenation, but independent of ACSL4
Ferroptosis has been linked to the levels of poly-unsaturated fatty acids (PUFAs) in cellular membranes, which are particularly prone to oxygenation (Fig 3A) [6, 7, 25] .
Therefore, in order to further characterize cell-density dependent ferroptosis, we undertook a series of experiments modulating PUFA-incorporation and -oxygenation.
Recent studies showed that ACSL4, which plays a key role in lipid biosynthesis and fatty acid degradation, is an essential enzyme for ferroptosis execution [6, 7] . ACSL4 increases the PUFA-content within phospholipids, which are susceptible to oxidation. In turn, lipoxygenases (LOX) generate oxygenated phospholipids that serve as a death signal for ferroptosis unless they are reduced by GPX4. Consequently, blocking ACSL4 activity by rosiglitazone (ROSI) or LOX activity by PD146176 or BWA4C was shown to protect against ferroptosis [6, 9, 25] . Lip1, Fer1, or the lipophilic antioxidant α-tocopherol (α-toc) can also prevent accumulation of lipid oxygenation and thus, execution of ferroptosis. Moreover, since the labile iron pool (redox-active Fe 2+ ) contributes to lipid oxygenation via the Fenton reaction, chelation of iron by deferoxamine (DFO) or cyclopirox (CPX) protects against ferroptosis ( Fig 3A) [1].
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To understand why cells die in a cell-density dependent manner, we tested the ability of the aforementioned inhibitors to rescue RSL3-induced cell death. Thus, we observed that iron-chelation by DFO, but not CPX, partially rescued RSL3-induced cell death in both HMLE and HMLE-Twist1 cells (28% to 72% viability in HMLE and 17% to 55% viability in HMLE-Twist1 cells upon DFO-co-treatment, Figure 3B ). In contrast to DFO, CPX directly chelates iron intracellularly and thereby affects iron-containing enzymes as well [26] , suggesting that excessive iron chelation might produce opposing effects.
Inhibition of lipoxygenases by both PD146176 and BWA4C, as well as the antioxidant α-toc, rescued RSL3-induced cell death (Fig 3B) . Together, these results suggested that oxygenated PUFA-containing lipids contribute to density-dependent cell death (Fig 3B) , in line with recent studies showing that LOX enzymes oxidize PUFAs, thereby sensitizing them to ferroptosis [9, 25] . To assess whether ACSL4 contributes to the intracellular PUFA-containing lipid pool, cells were pre-treated with ROSI prior to treatment with RSL3 to allow changes in the lipid profile to occur. Surprisingly, ROSI treatment did not rescue cell-death induction in HMLE and HMLE-Twist1 cells upon RSL3-treatment (Fig 3B) . Importantly, none of the employed inhibitors showed cytotoxic effects on HMLE and HMLE-Twist1 when applied alone (Fig 3B) . ROSI is an agonist of the peroxisome proliferation-activated receptor-γ (PPAR-γ), and ACSL4 inhibition is only an off-target effect [27] . Therefore, to validate whether ACSL4 contributes to densitydependent cell death, we performed a CRISPR/Cas9-mediated ACSL4 knockout in HMLE GPX4-KO SCCs (Fig 3C, 1G and 1H ). We derived several clones with ACSL4 knockout (ACSL4-KO: A1, A3, A4, A5, A7 and A8) and control clones with intact ACSL4 expression (A2 and A6 respectively, Fig 3C) . Unexpectedly, all clones died irrespective of ACSL4 expression in a cell-density dependent manner upon withdrawal of Lip1 ( The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint 3C, lower panel), suggesting that ferroptosis occurred independently of ACSL4. Of note, we cannot rule out that another ACSL enzyme compensated for ACSL4 activity, since ACSL3 can use PUFAs as a substrate as well [28, 29] .
To determine whether levels of oxidized lipids correlated with ferroptosis sensitivity, we measured lipid-derived reactive oxygen species (ROS) levels using the fluorescent dye BODIPY 581/591 C11 [30] . Consistently with previous observations [1, 9, 21] , we noticed an increase in C11 fluorescence in GPX4 knockout cells upon Lip1-withdrawal in both HMLE and HMLE-Twist1 cells at all densities (Fig 3D and E) . However, this increase in C11 greatly varied between different SCCs (Fig 3D) , although all of them were similarly sensitized to ferroptosis at low seeding densities (Fig 1H) . On average, C11 fluorescence increased at least 2-fold upon Lip1-withdrawal in HMLE GPX4-KO SCCs irrespective of seeding density (Fig 3E) . Interestingly, HMLE-Twist1 GPX4-KO SCCs seeded at an intermediate density showed the strongest accumulation of C11 fluorescence (5-fold on average, Fig 3E) . In summary, Lip1-withdrawal led to an increase in lipid-derived ROS levels in HMLE and HMLE-Twist1 GPX4-KO SCCs in all seeding densities. Therefore, the observed increase in lipoxygenation did not correlate with induction of ferroptosis. Consequently, these data suggest that cells at high and low seeding densities cope differently with an increase in lipid-derived ROS levels, rather than cell density having a strong impact on overall levels of lipoxygenation.
Proteomics reveal a density-dependent metabolic switch that sensitizes cells to
ACSL4-independent ferroptosis
Given the observed disconnection between lipoxygenation levels and cell death induced by inhibition or loss of GPX4, we next assessed why HMLE and HMLE-Twist1 cells . CC-BY-NC-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint plated at high cell density were resistant to ferroptotic cell death whereas cells plated at low cell density were sensitive. To do so, a proteomic study was performed to assess which proteins were differentially expressed at high and low cell densities alone and upon GPX4-inhibition through RSL3-treatment (Fig 4A) . For data analysis, we focused on upregulated proteins, by at least 1.5-fold in low cell density compared to high cell density in both HMLE and HMLE-Twist1 cells (190 proteins, p<0.05) . Further, we selected proteins that were upregulated at least 1.5-fold upon RSL3-treatment in both cell lines compared to non-RSL3 treated controls (274 proteins, p<0.05). Furthermore, we assessed the upregulated overlapping proteins (119 proteins) between low cell density and RSL3 treatment, with the rationale that these proteins are potentially involved in cell-density dependent death. The obtained list of 119 proteins was submitted to GO-term enrichment analysis (biological processes) using DAVID (Fig 4A and EV3A) [31, 32] . The GO-term "positive regulation of triglyceride catabolic process" within the top-ten regulated pathways attracted our attention, since GPX4 is crucial for removal of lipid peroxides within phospholipid membranes (Fig 4A and EV3A ).
Within this list, we decided to focus on adipose triglyceride lipase (ATGL = PNPLA2), which is the initial enzyme for triacylglyceride (TAG) hydrolysis and is regulated by its co-activator ABHD5 [33] . Functionally, ATGL catalyzes TAGs from intracellular lipid droplets (LDs), reducing LD abundance [34] . We validated ATGL expression by immunoblotting and observed an upregulation of ATGL in both HMLE and HMLE-Twist1 cells at low compared to high seeding densities ( Fig 4B) . Next, we stained neutral TAGs with the fluorescent dye BODIPY493/503 which is commonly used to assess the content of lipid droplets within cells [34] . Thereby, we observed a positive correlation between BODIPY493/503 fluorescence and seeding density in both HMLE and HMLE-Twist1 . CC-BY-NC-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint cells (Fig 4C) . Cells at high density showed a higher fluorescence intensity which decreased in lower seeding densities (Fig 4C) , indicating that cells at low density have a lower lipid-droplet content compared to cells at higher density. In contrast, we observed the opposite effect when we stained for basal lipid ROS by C11-BODIPY. Both HMLE and HMLE-Twist1 cells showed an elevation of lipid ROS levels from high to low seeding densities (Fig 4C) . Next, we inhibited ATGL by pre-incubating both HMLE and HMLE-Twist1 cells with the ATGL inhibitor Atglistatin (ATG) prior GPX4-inhibition by RSL3 at low density. RSL3-induced cell death was rescued by simultaneous ATG treatment in both HMLE and HMLE-Twist1 cells without affecting viability in control treatments ( Fig 4D) . Moreover, ATGL inhibition by ATG also rescued cell death induced by Lip1-withdrawal in GPX4-KO SCCs H5 and HT1 (Fig EV3B) . Together, these data suggested that cell density regulates ATGL expression in order to liberate fatty acids from TAGs stored in LDs. This in turn increased lipid-mediated stress in cells at low density, inducing a vulnerability towards simultaneous GPX4 inhibition.
Several reports suggest that in well-fed cells fatty acids are stored as TAGs within LDs and that starvation or cellular stress lead to a release of fatty acids from LDs by cytoplasmic lipases such as ATGL. These fatty acids are then transferred to mitochondria for oxidative metabolism [35] [36] [37] . Thus, we aimed to determine whether the upregulation of ATGL-mediated LD degradation served to satisfy changing metabolic needs at low cell density. Indeed, we observed that enzymes required for β-oxidation such as the Carnitine Palmitoyltransferase 1A (CPT1A) or the Acetyl-CoA Acyltransferase 2 (ACAA2) were upregulated at low compared to high density in the proteomic data set in both HMLE and HMLE-Twist1 cells (Supplemental Table 1 ). By RT-qPCR, we verified density-dependent regulation of both CPT1A and ACAA2 in each .
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The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint cell line (Fig 4E and EV3C ). We then measured basal mitochondrial ROS levels by MitoSox staining and detected an increase in MitoSox fluorescence in a densitydependent manner, suggesting an increased production of mitochondrial ROS at low density, possibly due to an increased rate of β-oxidation (Fig 4F) . To examine this further, we treated HMLE and HMLE-Twist1 cells with Etomoxir (ETX) to inhibit CPT1A, the rate-limiting enzyme for β-oxidation. However, ETX-treatment alone decreased cell viability in both HMLE and HMLE-Twist1 cells (Fig 4G) , suggesting that β-oxidation generally serves as an important energy source in these cells. Of note, a combination of ETX and RSL3 treatment had only minor effects on cell death induction at low cell density compared to treatment with each drug alone ( Fig 4G) . Moreover, in GPX4-KO SCCs HT1 and H5, ETX treatment alone reduced viability compared to controls in all densities ( Fig EV3D) . However, cells at the lowest cell density were around 1.5-fold less viable than cells in the highest density, suggesting an increased sensitivity to inhibition of β-oxidation at low cell density ( Fig EV3D) . Upon Lip1-withdrawal and thus GPX4 knockout, we did not observe strong additive effects upon ETX-treatment ( Fig EV3D) .
Thus, HMLE and HMLE-Twist1 cells appear to rely heavily on β-oxidation, with cells at low density being further sensitized to its inhibition. Together our data suggest that cell density regulates ATGL-mediated LD degradation in order to fuel β-oxidation at low density.
Stimulating β-oxidation through catabolism of LDs could be relevant to drive breast cancer metastasis, especially during stages where cells are disseminated as single cells or small clusters [37] [38] [39] . Thus, a metabolic switch to increased β-oxidation induced by cell density appears to occur at the expense of inducing a vulnerability towards lipid peroxidation. Based on these considerations, we asked whether increasing the LD .
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint amount by other means than ATGL inhibition could likewise decrease lipid-mediated stress and thus lower toxicity of GPX4-inhibition at low cell density. Previous studies have shown that culturing cells with the mono-unsaturated fatty acid oleic acid (OA) increases the lipid droplet content within cells [34] . Based on these considerations, we fed HMLE and HMLE-Twist1 cells with 100 µM OA for 24h and assessed LD content by BODIPY493/503 staining. For both cell lines, we observed an increase in LD content upon OA treatment in all densities compared to control (Fig 4H, left panel) . Interestingly, feeding OA to cells also decreased lipid ROS levels compared to controls ( Fig 4H, right panel), indicating a negative correlation between lipid droplet amount and ROS levels.
We then assessed viability upon GPX4 inhibition by RSL3 of control and OA-treated HMLE and HMLE-Twist1 cells. OA completely rescued RSL3-induced cell death induced at low and intermediate seeding densities (Fig 4I) , whereas OA treatment alone only had a minor impact on cell viability (Fig EV3E) . Together, these data suggest that culturing cells with OA protects them from lipid-stress induced by liberation of fatty acids from LDs, thereby providing a possible explanation for the beneficial effect of OA in rescuing RSL3-induced ferroptosis that has already been reported in other cancer cell lines [25] .
Based on these considerations, we hypothesized that ATGL-mediated TAG degradation, required for β-oxidation, might lead to toxic accumulation of lipid ROS upon GPX4 inhibition through peroxidation of these liberated fatty acids. This mechanism appears to be independent of ACSL4 expression that increases oxidation-prone PUFAs in membranes as ACSL4 knockout did not rescue ferroptotic cell death at low density ( Fig   3F) [6, 7] . Moreover, we did not observe a direct correlation between overall lipid ROS levels and cell death upon GPX4-knockout (Fig 1, Fig 3C and D) . In line with these observations, it was recently reported that every measure leading to a reduction of .
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint autoxidizable lipids, particularly PUFAs, will inhibit ferroptosis [40] . Thus, influencing LD content and turnover by changing the fraction of less oxidation-prone fatty acids such as OA might buffer lipotoxic effects, as was recently proposed [37, 41] . Supporting our findings, it was previously determined that cells at high density have an increased cellto-cell heterogeneity in lipid droplet content, which was suggested to reduce lipotoxicity for the whole population [42] .
In summary, we have shown that cell density plays a critical role in determining sensitivity to ferroptosis in both primary mammary epithelial and breast cancer cells.
This sensitivity is associated with cell-density dependent regulation of lipid droplets and thus liberation of fatty acids, serving as a source for β-oxidation. Future studies will be needed to determine whether this metabolic switch serves to protect epithelial tissue integrity. Given the recognition that, at least for melanoma, cellular antioxidant potential is required for efficient metastasis [43] , this mechanism might provide a strategy to target breast cancer cells during stages of metastasis, where they are present as single or small clusters of cells, for example following systemic dissemination into distant tissues.
Materials and Methods

Chemicals
The following chemicals were purchased from Sigma: Atglistatin, α-tocopherol, Bovine serum albumin (BSA), BW4AC, Ciclopriox, Deferoxamine, Dimethyl sulfoxide (DMSO), Doxorubicine hydrochloride, Etomoxir, Ferrostatin-1, Liproxstatin-1, Necrostatin-1S, Oleic Acid-Albumin from bovine serum, PD146176, Rosiglitazone. RSL3 was purchased from Cayman Chemical. z-VAD-fmk was purchased from R&D Systems.
Cell lines
Primary mammary epithelial cells were isolated and cultured as previously described [22] . Immortalized HMLE cells were generated by retroviral transduction of SV40 large T early region and catalytic subunit of human telomerase enzyme (hTERT) [44] . HMLETwist1 were subsequently generated by transduction with a pBabe-Puro-Twist1 vector, leading to constitutive Twist1-overexpression and a mesenchymal phenotype [45] .
HMLE-Ras cells were generated by introduction of a pBabe-Puro-Ras (V12H) retroviral vector [44] and HMLE-neu-NT cells with a pWZL-vector containing a mutated form of the HER2/neu oncogene [11] . Cells were grown in a 37°C incubator with a humidified atmosphere of 5% CO 2 , except for primary cells, which were maintained at 3% oxygen level if not otherwise stated. All cells were cultured in mammary epithelial cell growth medium containing 0.004 ml/ml BPE, 10 ng/ml EGF, 5 µg/ml Insulin and 0.5 µg/ml hydrocortisone (PromoCell) supplemented with 1% Pen/Strep (Invitrogen) (MECGM).
For GPX4-knockout single cell clones of HMLE and HMLE-Twists1 cells (for generation see CRISPR/Cas9-mediated knockout of individual genes section), 500 nM to 1 µM Lip1 was additionally added to MECGM. Inducible HMLE-Twist1-ER cells and HMLE-Snail1-.
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To visualize cell death induced by RSL3, HMLE and HMLE-Twist1 cells were plated in 6-well plates at a density of 90000 (high), 30000 (med) and 10000 (low) cells, corresponding to 3000 (high), 1000 (med) and 333 (low) seeded cells per well of 96-wells plates. The next day, cells were treated with 0.1% DMSO or 100 nM RSL3 and 20-24h later, bright-field images were taken on a Leica DM IL LED microscope.
Viability Assays
To measure the viability of cells in different densities, cells were seeded in 96-wells plates at a density of 3000, 1000 and 333 cells per well (high, med and low respectively, 3-6 technical replicates). Treatment with DMSO control or RSL3 was started one day after plating and cells were treated for 20-24h. For rescue-experiments (Fig 1E and 3B ), cells were seeded at a density of 600 cells per well. Compounds employed in viability assays were added during RSL3 treatment, except for Rosiglitazone, Oleic acid and Atglistatin (additionally 24-48h pre-treatment). For assessment of the viability of CRISPR/Cas9 GPX4-knockout clones and GPX4/ACSL4-knockout clones, Lip1 was withdrawn from the medium directly on the day of plating. For all experiments, viability was measured 48h after plating using CellTiter-Glo assay (Promega). CellTiter-Glo assay is a luciferase-based assay that measures endogenous ATP levels that correlate with the number of metabolically active, and thus viable cells. Luminescence was detected using the Luminometer Centro XS 3 LB 960 (Berthold Technologies). Obtained RLU values were averaged and normalized to respective DMSO control or Lip1 control.
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RNA preparation and RT-qPCR Analysis
For density experiments, 200000, 66000 and 22000 cells (high, med and low) were seeded in 6-cm dishes which corresponds to 3000, 1000 and 333 cells in 96-wells. Two days after plating, mRNA was isolated using the RNeasy Mini Kit (Qiagen) according to manufacturer's instructions. 1 µg total RNA was reverse transcribed using Oligo(dT) primers for amplification (OneScript cDNA Kit, abm). For qPCR, specific primers were For GPX4 and ACSL4 knockout, string assembly gRNA cloning (STAgR) was employed . Medium was replaced every 2 days and gels were fixed with 4% paraformaldehyde (PFA, Sigma) after 7-11 days of culture. Carmine staining and imaging was performed as previously described [22] . Pictures were analyzed by ImageJ software. For this purpose, images were first converted to a binary image and colonies extracted from the background by setting a manual threshold. Particles with an area between 400 and 90000 µm 2 (20-300 µM diameter) and a circularity 0.5-1 were counted. 3D
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immunofluorescence was performed as previously described [22] . Primary antibodies .
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Proteomic analysis of cells seeded in cell density
516000, 172000 and 57000 cells (high, med and low) were seeded on 10-cm dishes, corresponding to 3000, 1000 and 333 cells in 96-wells. For RSL3 treatment, cells at intermediate density were treated the next day for 5h with 100 nM RSL3 prior isolation of proteins. Proteins of cells were isolated 48h after seeding. Protein isolation and concentration measurement was performed as described in immunoblotting section.
MS sample preparation
10 µg of sample were enzymatically digested using a modified filter-aided sample preparation (FASP) protocol [48, 49] . Peptides were stored at -20°C until MS measurement.
MS measurement
Mass spectrometry (MS) measurements were performed in data dependent (DDA) mode. MS data were acquired on a Q Exactive (QE) high field (HF) mass spectrometer (Thermo Fisher Scientific Inc.). Approximately 0.5 μg per sample were automatically loaded to the online coupled RSLC (Ultimate 3000, Thermo Fisher Scientific Inc.) HPLC system. A nano trap column was used (300 μm inner diameter (ID) × 5 mm, packed with Acclaim PepMap100 C18, 5 μm, 100 Å; LC Packings, Sunnyvale, CA) before separation by reversed phase chromatography (Acquity UPLC M-Class HSS T3 Column 75µm ID x .
CC-BY-NC-ND 4.0 International license is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint 250mm, 1.8µm; Waters, Eschborn, Germany) at 40°C. Peptides were eluted from column at 250 nl/min using increasing acetonitrile (ACN) concentration (in 0.1% formic acid) from 3% to 41 % over a 105 minutes gradient. The high-resolution (60 000 full width at half-maximum) MS spectrum was acquired with a mass range from 300 to 1500 m/z with automatic gain control target set to 3 x 10 6 and a maximum of 50 ms injection time. From the MS prescan, the 10 most abundant peptide ions were selected for fragmentation (MSMS) if at least doubly charged, with a dynamic exclusion of 30 seconds. MSMS spectra were recorded at 15 000 resolution with automatic gain control target set to 1 x 10 5 and a maximum of 100 ms injection time. Normalized collision energy was set to 28 and all spectra were recorded in profile type.
Progenesis QI for label-free quantification
Spectra were analyzed using Progenesis QI software for proteomics (Version 3.0, Nonlinear Dynamics, Waters, Newcastle upon Tyne, U.K.) for label-free quantification as previously described [49] with the following changes: spectra were searched against the Swissprot human database (Release 2017.02, 553473 sequences). Search parameters used were 10 ppm peptide mass tolerance and 20 mmu fragment mass tolerance.
Carbamidomethylation of cysteine was set as fixed modification and oxidation of methionine and deamidation of asparagine and glutamine was allowed as variable modifications, allowing only one missed cleavage site. Mascot integrated decoy database search was set to a false discovery rate (FDR) of 1 %.
Analysis of proteomic study
Proteins were filtered for a regulation of at least 1.5-fold in RSL3 treatment compared to non-RSL3 treated control and a regulation of at least 1.5-fold in the lowest cell density compared to the highest cell density for both HMLE and HMLE-Twist1 cells. Only .
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The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint proteins with a p-value below 0.05 (unpaired, two-tailed T-test with Welch's correction on log2 expression data) were submitted to GO term enrichment analysis using DAVID [31, 32] . Potential hits were further analyzed by functional assays.
Data presentation and statistical analyses
Data are presented as mean ± SEM of n = x experiments, with x indicating the number of independent experiments performed, unless stated otherwise. Statistical analysis was performed using GraphPad Prism 7.0 software or Excel 2016. In general, an unpaired, two-tailed T-test was performed with Welch's correction and a p-value below 0.05 was considered significant. E. Confocal microscopy of 3D-collagen gels: staining of colonies quantified in Figure 2D with Ki67 (red), vimentin (green) or DAPI (blue, nuclear staining). The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/417949 doi: bioRxiv preprint each seeding density and cell line. Statistics: two-tailed, unpaired T-test with Welch's correction (p-value: *<0.05, **<0.01, ***0.001, ****<0.0001, n.s. = not significant). 
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